Profund Advisors LLC Innoviva, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$14.4 - $16.4 $7,012 - $7,986	-487 Reduced 4.07%	11,490 $188,000
Q1 2024 May 08, 2024	SELL	$14.56 - $16.78 $5,096 - $5,873	-350 Reduced 2.84%	11,977 $182,000
Q4 2023 Feb 14, 2024	BUY	$12.32 - $16.27 $5,519 - $7,288	448 Added 3.77%	12,327 $197,000
Q3 2023 Nov 13, 2023	BUY	$12.37 - $13.89 $10,774 - $12,098	871 Added 7.91%	11,879 $154,000
Q2 2023 Aug 10, 2023	SELL	$11.39 - $13.72 $29,762 - $35,850	-2,613 Reduced 19.18%	11,008 $140,000
Q1 2023 May 11, 2023	BUY	$10.73 - $13.6 $146,153 - $185,245	13,621 New	13,621 $153,000
Q3 2021 Nov 12, 2021	SELL	$13.06 - $17.24 $149,902 - $197,880	-11,478 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$11.45 - $13.96 $8,014 - $9,772	700 Added 6.49%	11,478 $154,000
Q1 2021 May 14, 2021	SELL	$11.06 - $12.87 $10,606 - $12,342	-959 Reduced 8.17%	10,778 $129,000
Q4 2020 Feb 09, 2021	BUY	$9.33 - $12.48 $109,506 - $146,477	11,737 New	11,737 $145,000
Q3 2020 Nov 13, 2020	SELL	$10.33 - $14.49 $113,041 - $158,564	-10,943 Closed	0 $0
Q2 2020 Aug 03, 2020	BUY	$11.49 - $15.26 $125,735 - $166,990	10,943 New	10,943 $153,000
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $92,145 - $173,043	-11,362 Closed	0 $0
Q4 2019 Feb 18, 2020	BUY	$10.28 - $14.38 $7,082 - $9,907	689 Added 6.46%	11,362 $161,000
Q3 2019 Nov 12, 2019	SELL	$10.05 - $14.55 $9,758 - $14,128	-971 Reduced 8.34%	10,673 $112,000
Q2 2019 Aug 13, 2019	SELL	$13.1 - $14.95 $17,383 - $19,838	-1,327 Reduced 10.23%	11,644 $170,000
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $118,733 - $173,980	-8,673 Reduced 40.07%	12,971 $182,000
Q4 2018 Feb 14, 2019	SELL	$13.96 - $18.26 $148,297 - $193,975	-10,623 Reduced 32.92%	21,644 $378,000
Q3 2018 Nov 13, 2018	BUY	$13.63 - $15.7 $224,336 - $258,406	16,459 Added 104.12%	32,267 $492,000
Q2 2018 Aug 13, 2018	BUY	$13.44 - $17.59 $17,337 - $22,691	1,290 Added 8.89%	15,808 $218,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.99 $42,476 - $52,295	3,078 Added 26.91%	14,518 $242,000
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $15,413 - $19,381	1,314 Added 12.98%	11,440 $162,000
Q3 2017 Nov 13, 2017	SELL	$12.06 - $14.12 $61,433 - $71,927	-5,094 Reduced 33.47%	10,126 $143,000
Q2 2017 Aug 11, 2017	BUY	N/A	15,220	15,220 $195,000

Others Institutions Holding INVA

# of Institutions

228

Shares Held

78.9M

Call Options Held

37.6K

Put Options Held

300

Black Rock Inc. New York, NY

9.63M
Shares

$166 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

7.28M
Shares

$126 Million
34.93% of portfolio
Franklin Resources Inc San Mateo, CA

6.75M
Shares

$117 Million
0.04% of portfolio
Putnam Investments LLC Boston, MA

6.27M
Shares

$108 Million
0.14% of portfolio
Vanguard Group Inc Valley Forge, PA

6.23M
Shares

$108 Million
0.0% of portfolio

View Full List

About Innoviva, Inc.

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.2B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

More about INVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account